by Five Rivers Rx | May 20, 2020 | DEA, Industry News, Suspicious Order Monitoring
Omnicare, a leading provider of closed-door pharmacy services, agreed to pay more than a $15 million civil penalty for allowing opioids and other controlled substances to be dispensed without a valid prescription. The fine zeroes in on a common issue amongst...
by Five Rivers Rx | May 20, 2020 | Drug Manufacturers, Industry News
Even as the COVID-19 pandemic disrupts day-to-day life, the fight over drug pricing transparency rages on between consumer groups, regulators, and industry. Regulators are assessing significant fines to increase compliance. Fines in California & Nevada Over...
by Five Rivers Rx | May 6, 2020 | Industry News
Optum Rx’s requirement for their network pharmacies to only purchase prescription drug and diabetic testing supplies from Accredited wholesalers has caused significant disruption and controversy since its implementation in August 2016. The requirement spurred two...
by Five Rivers Rx | May 6, 2020 | Industry News
In 2019, Minnesota announced an increase in registration fees for wholesalers and manufacturers from $235 per year to $5,260 (read more information here). The 2,200% increase for Minnesota fees has created an unprecedented barrier to entry for small wholesalers and...
by Five Rivers Rx | May 6, 2020 | Puerto Rico
Five Rivers RX continues to stay on top of developments with the Puerto Rico Department of Health’s portal. In early April, issues with their technology provider brought the entire web portal down, preventing submission for both drug registrations and controlled...
